Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

NCT00418704 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Erlotinib
DRUG: taxotere

Sponsor

Groupe Francais De Pneumo-Cancerologie

Collaborators

[object Object]
[object Object]